Buy GTx Stock | GTXI Stock Price & Latest News | Public.com
GTXI

GTx

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View GTx (GTXI) stock trends here

    About GTXI

    Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Cirmtuzumab, TK216, and ROR1 CAR-T. The company was founded by David F. Hale and James B. Brei...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$283,84M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$10.56
    1 Year Low$1.49
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app